GHISLAINE MAXWELL ACCT For the Period 711/12 to 7/31/12 Account Summary Asset Allocation Beginning Ending Change Estimated Current Asset Allocation Market Value Market Value In Value Annual Income Allocation Equity Alternative Assets 699,453.63 702,849.78 3,396.15 45,693.48 10% 73,807.67 74,867.63 1,059.96 1% Cash 8 Fixed Income 7,279,499.92 7,310,742.47 31,242.55 49,399.13 88% Other 88 527.17 91 365.48 2.83831 1% Market Value Accruals $8.141,288.38 $8,178,826.36 539,636.97 20,140 41 1339508 (6 745 33) 996,092.61 100% Market Value with Accruals 58,161,428.80 $8,193,220.44 $31.791.64 Portfolio Activity Current Year-to-Cate Period Value Value Beginning Market Value 8,141,288.39 4.926.904.29 Contributions VVithdrawals & Fees Secunties Transferred In 4.972.947 20 (201.35) (2,080,496.26) 1,263,208.64 10,437,467.27 Securities Transferred Out 1 261 872.26 10 332 905.21 Net ContrlbutlonslWithdrawals Income 8. Distributions 81,135.03 22,997,013.00 19,025.53 66,703.43 Change In Investment Value 18.376.41 189.204 64 Ending Market Value Accruals 38.178,826.38 58,179,826.36 13,395.08 13.395 08 Market Value with Accruals $8,193,220.44 58.193.220.44 JP Morgan Other Alfa Maw Assay Equity Cash Find Income Page 2 of 31 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00048667 SDNY_GM_00317865 EFTA01521293